Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 11,500.00
Ask: 12,270.00
Change: 0.00 (0.00%)
Spread: 770.00 (6.696%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Nigeria destroys 1 mln donated AstraZeneca vaccines with short shelf life

Wed, 22nd Dec 2021 14:12

* Vaccine shortage spurred Nigeria to accept the doses

* Rich nations had donated the shots with expiry looming

* Destruction meant to spur residents' confidence in vaccine
program

* Recent surge in supply brings new distribution challenges

*

By Camillus Eboh

ABUJA, Dec 22 (Reuters) - Nigeria on Wednesday destroyed
more than a million doses of expired AstraZeneca
vaccines in a bid to assure a wary public that they have been
taken out of circulation.

The destruction came more than a week after health
authorities said some COVID-19 doses donated by rich Western
nations had a shelf life that left only weeks to administer the
shots. Reuters reported on Dec. 7 that around one million
COVID-19 vaccines were estimated to have expired in Nigeria in
November without being used.

At a dump site in Abuja, a bulldozer crushed AstraZeneca
shots that were packed in cardboard boxes and plastic as
reporters and health officials watched.

Faisal Shuaib, the National Primary Health Care Development
Agency executive director told reporters that a shortage of
vaccine supplies on the continent, had forced Nigeria to take
the doses, knowing fully well they had a short shelf life.

"We have successfully withdrawn 1,066,214 doses of expired
AstraZeneca vaccines. We have kept our promise to be transparent
to Nigerians. The destruction today is an opportunity for
Nigerians to have faith in our vaccination programme," Shuaib
said.

Governments on the continent of over one billion people have
been pushing for more vaccine deliveries as inoculation rates
lag richer regions. The lower vaccination levels raise the risk
of higher infection and death rates from COVID-19, especially as
new, fast-spreading variants emerge such as Omicron.

Health minister Osagie Ehanire has said Nigeria will no
longer accept vaccines with a short shelf life, citing a
presidential committee decision.

The World Health Organisation said 12,971,729 vaccine doses
have been administered in Nigeria as of Dec. 19.

Africa's most populous country, with a population exceeding
200 million, has recorded 227,378 COVID-19 cases and 2,989
deaths since the pandemic started.

Health experts say Nigeria needs to triple its vaccination
drive from just over 100,000 doses a day to meet its target to
inoculate more than half its population by the end of next year.

Recently, like many other African countries, Nigeria has
seen a surge in vaccine supply, which has highlighted other
issues relating to distribution and hesitation by citizens to
get inoculated.
(Writing by MacDonald Dzirutwe;
Editing by Bernadette Baum)

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.